TCRX - Tscan Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TCRX is currently covered by 3 analysts with an average price target of $8.35. This is a potential upside of $6.04 (261.47%) from yesterday's end of day stock price of $2.31.

Tscan Therapeutics's activity chart (see below) currently has 20 price targets and 28 ratings on display. The stock rating distribution of TCRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.33% with an average time for these price targets to be met of 66.5 days.

Highest price target for TCRX is $3, Lowest price target is $3, average price target is $3.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 08-Apr-2025. First documented stock forecast 10-Aug-2021.

Best performing analysts who are covering TCRX - Tscan Therapeutics:

David Nierengarten Andrew Fein Gil Blum Peter Lawson

Currently out of the existing stock ratings of TCRX, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$9

6 months 17 days ago
(08-Apr-2025)

0/6 (0%)

$7.08 (368.75%)

Buy

$3

$0.69 (29.87%)

$14

7 months 18 days ago
(07-Mar-2025)

1/3 (33.33%)

$1.02 (51.52%)

74

Buy

$15

7 months 19 days ago
(06-Mar-2025)

0/10 (0%)

$11.92 (387.01%)

Buy

$10

$7.69 (332.90%)

$10

1 years 2 months 12 days ago
(13-Aug-2024)

2/5 (40%)

$4.14 (70.65%)

192

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TCRX (Tscan Therapeutics) average time for price targets to be met?

On average it took 66.5 days on average for the stock forecasts to be realized with a an average price target met ratio 18.33

Which analyst has the current highest performing score on TCRX (Tscan Therapeutics) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on TCRX (Tscan Therapeutics) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on TCRX (Tscan Therapeutics)?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on TCRX

Which analyst is the currently most bullish on TCRX (Tscan Therapeutics)?

David Nierengarten with highest potential upside - $7.69

Which analyst is the currently most reserved on TCRX (Tscan Therapeutics)?

Andrew Fein with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?